Profil
Anthony R.
DiSanto is currently the Vice President of Drug Development at Alamo Pharmaceuticals LLC and the President of AAAgent Services LLC.
He previously worked as a Vice President at The Upjohn Co. He received his undergraduate degree from Philadelphia University and his graduate degree from the University of Michigan.
Aktive Positionen von Anthony DiSanto
| Unternehmen | Position | Beginn |
|---|---|---|
Alamo Pharmaceuticals LLC
 Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Anthony DiSanto
| Unternehmen | Position | Ende |
|---|---|---|
| The Upjohn Co. | Corporate Officer/Principal | - |
Ausbildung von Anthony DiSanto
| Philadelphia University | Undergraduate Degree |
| University of Michigan | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| The Upjohn Co. | Health Technology |
Alamo Pharmaceuticals LLC
Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Health Technology |
